Pertussis Vaccines

Clinical Trial for DTAP-IPV Vaccine Announced

Published in Vaccine Weekly, July 7th, 1997

North American Vaccine, Beltsville, Maryland, announced that it is has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) to conduct clinical trials in the United States with a DTaP-IPV vaccine which combines Certiva, the company's combined diphtheria, tetanus, and acellular pertussis vaccine, with an injectable inactivated polio vaccine.

The clinical trials, to be conducted at several clinical sites around the country, are designed to establish the safety and immunogenicity of this vaccine in infants and children.

In the clinical program, the DTaP-IPV vaccine will be administered to infants at two, four,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1997-07-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry